A carregar...
Long-term (up to 16 months) health-related quality of life after adjuvant tailored dose-dense chemotherapy vs. standard three-weekly chemotherapy in women with high-risk early breast cancer
PURPOSE: To prospectively compare HRQoL effects of two modern adjuvant chemotherapy breast cancer treatment regimens at six time-points up to 16 months after random assignment. METHODS: The open-label, randomized, Phase 3 “Panther trial” was conducted between February 2007 and September 2011. 760 wo...
Na minha lista:
Publicado no: | Breast Cancer Res Treat |
---|---|
Main Authors: | , , , , , , , |
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
Springer US
2020
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7182635/ https://ncbi.nlm.nih.gov/pubmed/32232698 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10549-020-05602-9 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|